oral+semaglutide+approval FDA approves first-ever oral GLP-1RA for obesity and chronic weight management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only- oral-glp-1-for-weight-loss-in-adults Oral Obesity Drugs Edge Closer

The good news is that nerve damage doesnt always have to progress

These include GLP1/glucagon dual agonists (AstraZeneca, Boehringer Ingelheim, Hanmi Pharma, Eli Lilly) , GIP/GLP1/glucagon tri-agonists (Hanmi Pharmaceuticals, Eli Lilly), or solo GIPR agonists (Eli Lilly, Zealand Pharma)

Semaglutide and tirzepatide work by mimicking hormones involved in appetite regulation and glucose metabolism

Its availability exists in a highly restricted regulatory gray zone

and 2) a trial-product estimand which includes data collected from all randomized participants prior to premature trial-product discontinuation or initiation of rescue medication ( SIDEBAR 2 )